Page 403

World Rugby Handbook

REGULATION 21 APPENDIX 2 involved in Doping Control which does not otherwise constitute Tampering shall be addressed pursuant to Regulation 20 and/or its equivalent in Unions’ or Tournament Organisers’ regulations. Comment 7 (Regulation 21.2.6.1 and 21.2.6.2): Acceptable justification would not include, for example, buying or Possessing a Prohibited Substance for purposes of giving it to a friend or relative, except under justifiable medical circumstances where that Person had a physician’s prescription, e.g., buying Insulin for a diabetic child. Comment 8 (Regulation 21.2.6.2): Acceptable justification would include, for example, a team doctor carrying Prohibited Substances for dealing with acute and emergency situations. Comment 9 (Regulation 21.2.10): Players and other Persons must not work with coaches, trainers, physicians or other Player Support Personnel who are Ineligible on account of an anti-doping rule violation or who have been criminally convicted or professionally disciplined in relation to doping. Some examples of the types of association which are prohibited include: obtaining training, strategy, technique, nutrition or medical advice; obtaining therapy, treatment or prescriptions; providing any bodily products for analysis; or allowing the Player Support Person to serve as an agent or representative. Prohibited association need not involve any form of compensation. Comment 10 (Regulation 21.3.1): This standard of proof required to be met by World Rugby is comparable to the standard which is applied in most countries to cases involving professional misconduct. Comment 11 (Regulation 21.3.2): For example, World Rugby may establish an antidoping rule violation under Regulation 21.2.2 based on the Player’s admissions, the credible testimony of third Persons, reliable documentary evidence, reliable analytical data from either an A or B Sample as provided in the Comments to Regulation 21.2.2, or conclusions drawn from the profile of a series of the Player’s blood or urine Samples, such as data from the Player Biological Passport. Comment 12 (Regulation 21.3.2.2): The burden is on the Player or other Person to establish, by a balance of probability, a departure from the International Standard for Laboratories that could reasonably have caused the Adverse Analytical Finding. If the Player or other Person does so, the burden shifts to World Rugby to prove to the comfortable satisfaction of the hearing panel that the departure did not cause the Adverse Analytical Finding. Comment 13 (Regulation 21.4.1): The Prohibited List appears in Schedule 2 to these Anti-Doping Rules and is also always available in its full updated form and in a range of languages on WADA's website at www.wada-ama.org. Comment 14 (Regulation 21.4.2.2): The Specified Substances identified in Regulation 21.4.2.2 should not in any way be considered less important or less dangerous than other doping substances. Rather, they are simply substances which are more likely to have been consumed by a Player for a purpose other than the enhancement of sport performance. Comment 15 (Regulation 21.4.4.1 – 21.4.4.3): Further to Articles 5 – 6 and 4.1(a) of the International Standard for Therapeutic Use Exemptions, World Rugby may Last update: 14 January, 2015 403


World Rugby Handbook
To see the actual publication please follow the link above